We describe a case of a patient severe generalized psoriasis treated with etanercept, who developed deep ein thrombosis and 1 yeast lated developed solid lung cancer. Anti-tumor necrosis factor therapies have been a powerful addition to the therapy of psoriasis; nevertheless, the treatment might be associated eith adverse events, such as venous thromboembolism or malignancies.
Available data regarding these specific adverse reactions are rather conflictive; terefore, more observational studies and registry reports for long-term risk assessment are needed.